SEC Form 4 · accession 0001193125-26-350217
BELITE BIO, INC · BLTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yu-Hsin Lin
Officer — Chief Executive Officer · Director
Period of report
Aug 12, 2026
Accepted (ET)
Aug 14, 2026 · 6:10 am EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001889109
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American depositary shareF1 | Aug 12, 2026 | S | 142 | $180.00 | D | 170,792 | D | |
| American depositary shareF1 | Aug 12, 2026 | S | 223 | $180.57 | D | 170,569 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/23/2025.